Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
UBS
Cipla
Moodys
Federal Trade Commission
Teva
Deloitte
Chinese Patent Office
Covington
Harvard Business School

Generated: October 20, 2017

DrugPatentWatch Database Preview

Robins Ah Company Profile

« Back to Dashboard

What is the competitive landscape for ROBINS AH, and what generic and branded alternatives to ROBINS AH drugs are available?

ROBINS AH has ten approved drugs.



Summary for Applicant: Robins Ah

US Patents:0
Tradenames:10
Ingredients:7
NDAs:10
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Robins Ah
ROBINUL
glycopyrrolate
INJECTABLE;INJECTION014764-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Robins Ah
DIMETANE-DX
brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride
SYRUP;ORAL019279-001Aug 24, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Robins Ah
REGLAN
metoclopramide hydrochloride
SOLUTION;ORAL018821-001Mar 25, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe
Robins Ah
PHENAPHEN W/ CODEINE NO. 3
acetaminophen; codeine phosphate
CAPSULE;ORAL084445-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Robins Ah
TENATHAN
bethanidine sulfate
TABLET;ORAL017675-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Robins Ah
PHENAPHEN W/ CODEINE NO. 4
acetaminophen; codeine phosphate
CAPSULE;ORAL084446-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Robins Ah
PHENAPHEN W/ CODEINE NO. 2
acetaminophen; codeine phosphate
CAPSULE;ORAL084444-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Robins Ah
TENATHAN
bethanidine sulfate
TABLET;ORAL017675-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Robins Ah
ROBIMYCIN
erythromycin
TABLET, DELAYED RELEASE;ORAL061633-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Robins Ah
ROBAXISAL
aspirin; methocarbamol
TABLET;ORAL012281-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Robins Ah

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Robins Ah
TENATHAN
bethanidine sulfate
TABLET;ORAL017675-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Robins Ah
TENATHAN
bethanidine sulfate
TABLET;ORAL017675-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ROBINS AH drugs

Drugname Dosage Strength Tradename Submissiondate
glycopyrrolate
Tablets1 mg
ROBINUL
8/14/2009

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
AstraZeneca
Baxter
Healthtrust
Cantor Fitzgerald
Fish and Richardson
Johnson and Johnson
Citi
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot